InsidersTradesSigma
Follow the 科前生物 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 科前生物 has recorded 1 insider filings. Market capitalisation: €5.9bn. The latest transaction was reported on 19 July 2024 (Sale). Among the most active insiders: 叶长发. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
科前生物 is a company focused on the health and pharmaceutical sector, dedicated to the research and development of innovative biological solutions. It is listed on the XSHG market.